Michael Höckel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Höckel has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Lars-Christian Horn
Division of Breast, Gynecological and Perinatal Pathology, University of Leipzig, Leipzig, Germany
13 shared publicationsNadja Dornhöfer
Department of Gynecology and Obstetrics, University of Leipzig, Leipzig, Germany
6 shared publicationsBettina Hentschel
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
5 shared publicationsJens Einenkel
4 shared publicationsBenjamin Wolf
Department of Gynecology and Obstetrics, University of Leipzig, Leipzig, Germany
3 shared publications- Jens-Peer Kuska
Universität Leipzig
2 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Elsevier in EBioMedicine
- Vol. 126, 106161
The pathoanatomy of cancer: order in paradox
- 9 March 2026
- Published by Elsevier in EBioMedicine
- Vol. 126, 106161
Open AccessThe pathoanatomy of cancer: order in paradox
- Open Access
- 1 January 2021
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 7, 64
Cancer field surgery for locoregional tumor control of cervical carcinoma
Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
- 1 January 2021
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 7, 64
Open AccessCancer field surgery for locoregional tumor control of cervical carcinoma
Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
- 1 September 2019
- Published by Elsevier in The Lancet Oncology
- Vol. 20 (9) , 1316-1326
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study
- 1 September 2019
- Published by Elsevier in The Lancet Oncology
- Vol. 20 (9) , 1316-1326
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study
- Open Access
- 29 May 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 416
The Order of Cancer: A Theory of Malignant Progression by Inverse Morphogenesis
Local spread patterns of malignant tumors follow permissive tissue territories, i.e., cancer fields, as shown for cervical and vulvar carcinoma. The cancer fields are associated in reverse order to the mature derivatives of the morphogenetic fields instrumental in the stepwise development of the tissue from which the tumor arose. This suggests that cancer progression may be linked to morphogenesis by inversion of the cellular bauplan sequence. Successive attractor transitions caused by proliferation-associated constraints of topobiological information processing are proposed for both morphogenesis and cancer. In morphogenesis these transitions sequentially activate bauplans with increasing complexity at decreasing plasticity restricting the permissive territories of the progenitor cell populations. Somatic mutations leading to cell proliferation in domains normally reserved for differentiation trigger the inverse cascade of bauplan changes that increase topobiological plasticity at decreased complexity and stepwise enlarge the permissive territory of neoplastic cells consistent with the clinical manifestations of cancer. The order provided by the sequence of attractor transitions and the defined topography of the permissive territories can be exploited for more accurate tumor staging and for locoregional tumor treatment either by surgery or radiotherapy with higher curative potential.
- 29 May 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 416
Open AccessThe Order of Cancer: A Theory of Malignant Progression by Inverse Morphogenesis
Local spread patterns of malignant tumors follow permissive tissue territories, i.e., cancer fields, as shown for cervical and vulvar carcinoma. The cancer fields are associated in reverse order to the mature derivatives of the morphogenetic fields instrumental in the stepwise development of the tissue from which the tumor arose. This suggests that cancer progression may be linked to morphogenesis by inversion of the cellular bauplan sequence. Successive attractor transitions caused by proliferation-associated constraints of topobiological information processing are proposed for both morphogenesis and cancer. In morphogenesis these transitions sequentially activate bauplans with increasing complexity at decreasing plasticity restricting the permissive territories of the progenitor cell populations. Somatic mutations leading to cell proliferation in domains normally reserved for differentiation trigger the inverse cascade of bauplan changes that increase topobiological plasticity at decreased complexity and stepwise enlarge the permissive territory of neoplastic cells consistent with the clinical manifestations of cancer. The order provided by the sequence of attractor transitions and the defined topography of the permissive territories can be exploited for more accurate tumor staging and for locoregional tumor treatment either by surgery or radiotherapy with higher curative potential.
- 1 April 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (4) , 537-548
Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial
- 1 April 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (4) , 537-548
Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial
- Open Access
- 1 November 2017
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 22, 110
Resurrection of the rectus abdominis musculoperitoneal flap for pelvic exenteration?
- 1 November 2017
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 22, 110
Open AccessResurrection of the rectus abdominis musculoperitoneal flap for pelvic exenteration?
- 30 November 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 70, 99-110
Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis
- 30 November 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 70, 99-110
Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis
- 1 March 2015
- Published by Elsevier in The Lancet Oncology
- Vol. 16 (3) , e148-e151
Morphogenetic fields of embryonic development in locoregional cancer spread
- 1 March 2015
- Published by Elsevier in The Lancet Oncology
- Vol. 16 (3) , e148-e151
Morphogenetic fields of embryonic development in locoregional cancer spread
- 17 February 2015
- Published by Springer Nature in Current Oncology Reports
- Vol. 17 (3) , 1-6
Long-Term Experience with (Laterally) Extended Endopelvic Resection (LEER) in Relapsed Pelvic Malignancies
Gynecologic cancers recurring in the pelvis are generally advanced in malignant progression limiting curative treatment approaches. The cancer field theory links cancer progression to reversed morphogenesis and allows the exact anatomical delineation of the cancer field, i.e., the tissue compartment of potential tumor infiltration related to the tumor’s ontogenetic stage. Cancer surgery is redefined with the resection of ontogenetic stage-related cancer fields instead of the mere removal of the malignant tumor with an uninvolved tissue margin. Most gynecologic pelvic malignancies recurring in the pelvis represent ontogenetic stages 3 and 4. (Laterally) extended endopelvic resection ((L)EER) has been designed to resect the cancer fields of gynecologic tumors in these advanced ontogenetic stages. This paper reports long-term experience with (L)EER for relapsed pelvic malignancies strongly supporting the cancer field theory and the principle and practice of cancer field resection.
- 17 February 2015
- Published by Springer Nature in Current Oncology Reports
- Vol. 17 (3) , 1-6
Long-Term Experience with (Laterally) Extended Endopelvic Resection (LEER) in Relapsed Pelvic Malignancies
Gynecologic cancers recurring in the pelvis are generally advanced in malignant progression limiting curative treatment approaches. The cancer field theory links cancer progression to reversed morphogenesis and allows the exact anatomical delineation of the cancer field, i.e., the tissue compartment of potential tumor infiltration related to the tumor’s ontogenetic stage. Cancer surgery is redefined with the resection of ontogenetic stage-related cancer fields instead of the mere removal of the malignant tumor with an uninvolved tissue margin. Most gynecologic pelvic malignancies recurring in the pelvis represent ontogenetic stages 3 and 4. (Laterally) extended endopelvic resection ((L)EER) has been designed to resect the cancer fields of gynecologic tumors in these advanced ontogenetic stages. This paper reports long-term experience with (L)EER for relapsed pelvic malignancies strongly supporting the cancer field theory and the principle and practice of cancer field resection.
- 2 January 2015
- Published by Springer Nature
- p. 397-405
(Laterally) Extended Endopelvic Resection for the Treatment of Locally Advanced and Recurrent Cervical Cancer
- 2 January 2015
- Published by Springer Nature
- p. 397-405
(Laterally) Extended Endopelvic Resection for the Treatment of Locally Advanced and Recurrent Cervical Cancer